Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.50 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

vaccinogen inc (VGEN) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/4/15 - $4.90
52 Week Low
06/5/15 - $1.65
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VACCINOGEN INC (VGEN)

Related News

No related news articles were found.

vaccinogen inc (VGEN) Related Businessweek News

No Related Businessweek News Found

vaccinogen inc (VGEN) Details

Vaccinogen Inc., a biotechnology company, focuses on the development and commercialization of cancer vaccines and immunotherapeutic products for cancers in the United States. It primarily offers OncoVAX, a cancer vaccine for the post-surgical treatment of Stage II colon cancer. The company was founded in 2007 and is headquartered in Baltimore, Maryland.

24 Employees
Last Reported Date: 04/15/15
Founded in 2007

vaccinogen inc (VGEN) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $534.8K
Founder, Chairman Emeritus, Special Advisor, ...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2014.

vaccinogen inc (VGEN) Key Developments

Vaccinogen, Inc. Appoints Michael G. Hagerman to Its Board of Directors

Vaccinogen, Inc. announced the appointment of Michael G. Hagerman, Cofounder and Partner of ACT Medical Solutions Inc. to its Board of Directors. Mr. Hagerman brings more than 40 years of business and leadership experience and is an accomplished entrepreneur with a focus on advancing the field of personalised medicine. Mr. Hagerman will replace Ronald Kaiser, who is leaving the Board for personal reasons. Mr. Hagerman has founded and held CEO and senior leadership positions for a wide range of companies. Mr. Hagerman is currently the Cofounder and Partner of ACT Medical Solutions Inc., which offers medical diagnostic testing to labs around the world. He is also the Managing Director of Personalised Medicine Project, Child and Family Research Center, which works to translate new discoveries into medical tools and techniques for early, precise diagnoses, and serves as the founding President of DirectorsEdge Inc., which is dedicated to ensuring "best practices" on Corporate Boards. Mr. Hagerman is an active Board Member of InvestX.

Vaccinogen, Inc. Presents at Marcum Microcap Conference 2015, May-28-2015 04:00 PM

Vaccinogen, Inc. Presents at Marcum Microcap Conference 2015, May-28-2015 04:00 PM. Venue: Grand Hyatt New York, Park Avenue at Grand Central, New York, NY 10017, United States.

Vaccinogen, Inc. Replaces Benjamin S. Carson with Andrew L. Tussing as Chairman

Vaccinogen, Inc. announced that its Board of Directors has unanimously elected Co-founder, President, Chief Executive Officer and current Director, Andrew L. Tussing, to the role of Chairman of the Board. Mr. Tussing replaces Benjamin S. Carson, Sr., MD, who resigned from the Board and his role as Chairman and a member of the company's Medical Advisory Board role to pursue his candidacy for the President of the United States via the Republican nomination.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VGEN:US $2.50 USD 0.00

VGEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VGEN.
View Industry Companies

Industry Analysis


Industry Average

Valuation VGEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VACCINOGEN INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at